Совместимость Конвулекс® и ФармАмеропен
Страница описания препарата Конвулекс®
Страница описания препарата ФармАмеропен
Cтепень серьёзности/тяжести
Достоверность
Описание взаимодействия
Источники
Печатные издания
Panipenem-betamipron and decreases in serum valproic acid concentration
Ther Drug Monit /Volume:20 Part:4/Aug Page:396-400 / 1998 / Yamagata T, Momoi MY, Murai K et al
Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron
J Antimicrob Chemother /Volume:39 Part:2/Feb Page:295-6 / 1997 / Nagai K, Shimizu T, Togo A et al
Valproic acid-carbapenem interaction: report of six cases and a review of the literature
Drug Metabol Drug Interact /Volume:24 Part:2-4 Page:153-82 / 2009 / Tobin JK, Golightly LK, Kick SD et al
Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study
J Clin Pharmacol /Volume:49 Part:11/Nov Page:1363-9 / 2009 / Haroutiunian S, Ratz Y, Rabinovich B et al
Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient
J Geriatr Pharmacother /Volume:1 Part:7/Feb Page:26-33 / 2009 / Gu J, Huang Y
Acute seizures due to a probable interaction between valproic acid and meropenem
Ann Pharmacother /Volume:39 Part:3/May Page:533-7 / 2005 / Coves-Orts FJ, Borrass-Blasco J, Navarro-Ruiz A et al
Seizure worsening caused by decreased serum valproate during meropenem therapy
J Child Neurol /Volume:20 Part:5/May Page:456-457 / 2005 / Santucci M, Parmeggiani A, Riva R